Brigatte Patricia, Sampaio Sandra Coccuzzo, Gutierrez Vanessa Pacciari, Guerra José Luiz, Sinhorini Idércio Luiz, Curi Rui, Cury Yara
Laboratory of Pathophysiology, Butantan Institute, São Paulo, Brazil.
J Pain. 2007 May;8(5):412-21. doi: 10.1016/j.jpain.2006.11.006. Epub 2007 Feb 6.
An animal model of cancer pain induced by injection of Walker 256 carcinoma cells into the plantar surface of rat hind paw is described. Tumor growth and the occurrence of metastasis were investigated by histopathological analysis. Tumor cell growth was also analyzed plethysmographically by the increase in paw volume. For characterization of pain symptoms, hyperalgesia, allodynia, and spontaneous pain were evaluated 5 to 8 days after cell injection. The volume of the inoculated paw started to increase on day 2 after inoculation, being 40% higher on day 5 after injection. At this time, there was a marked proliferation of tumor cells, with the presence of anaplastic and pleomorphic cells, nucleoli, and atypical mitotic features. On days 7 and 8 after injection, histopathological analysis of popliteal lymph nodes showed the presence of tumor cells. The intraplantar injection of Walker 256 cells caused hyperalgesia at day 5 after cell inoculation. Low-threshold mechanical allodynia was significant 2 days after cell injection, being increased on day 5. In addition, inoculation of tumor cells induced gross behavior, characterized by a significant increase in licking and lifting of the injected paw 5 days after injection. The pain-enhancing effect caused by cell inoculation was partially inhibited by indomethacin on day 2 after cell injection, whereas morphine blocked allodynia on days 2 and 5. These results indicate that intraplantar injection of Walker 256 cells cause pain symptoms characteristic of cancer pain. This experimental model can then be used to investigate new analgesic or anti-tumor drugs.
This article presents a new animal model for studying cancer pain and metastasis. This model could help in understanding the mechanisms involved in cancer pain symptoms and may be used for the investigation of new analgesic or anti-tumor drugs.
描述了一种通过将Walker 256癌细胞注射到大鼠后爪足底表面诱导癌症疼痛的动物模型。通过组织病理学分析研究肿瘤生长和转移的发生情况。还通过爪体积增加的体积描记法分析肿瘤细胞生长。为了表征疼痛症状,在细胞注射后5至8天评估痛觉过敏、异常性疼痛和自发疼痛。接种爪的体积在接种后第2天开始增加,在注射后第5天高出40%。此时,肿瘤细胞有明显增殖,存在间变和多形性细胞、核仁以及非典型有丝分裂特征。在注射后第7天和第8天,腘窝淋巴结的组织病理学分析显示存在肿瘤细胞。在细胞接种后第5天,足底注射Walker 256细胞引起痛觉过敏。在细胞注射后2天,低阈值机械性异常性疼痛显著,在第5天加重。此外,接种肿瘤细胞诱导明显行为,其特征是在注射后5天舔舐和抬起注射爪的行为显著增加。细胞接种引起的疼痛增强效应在细胞注射后第2天被吲哚美辛部分抑制,而吗啡在第2天和第5天阻断异常性疼痛。这些结果表明,足底注射Walker 256细胞会引起癌症疼痛特有的疼痛症状。该实验模型可用于研究新的镇痛或抗肿瘤药物。
本文提出了一种用于研究癌症疼痛和转移的新动物模型。该模型有助于理解癌症疼痛症状所涉及的机制,并可用于研究新的镇痛或抗肿瘤药物。